We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAP icon
1201
PUT
Advance Auto Parts
AAP
$2.79B
$451K ﹤0.01%
+11,600
New +$580K
2026 Q3
0 quarters
STNE icon
1202
StoneCo
STNE
$1.66B
$450K ﹤0.01%
+48,180
New +$496K
2026 Q3
0 quarters
CVX icon
1203
Chevron
CVX
$402B
$448K ﹤0.01%
2,193
-9,209
-81% -$1.81M
2025 Q1
6 quarters
YUMC icon
1204
Yum China
YUMC
$17.1B
$448K ﹤0.01%
10,895
-9,355
-46% -$416K
2022 Q1
18 quarters
FIGR icon
1205
Figure Technology Solutions
FIGR
$5.87B
$446K ﹤0.01%
+15,451
New +$502K
2026 Q3
0 quarters
SSNC icon
1206
SS&C Technologies
SSNC
$17.9B
$445K ﹤0.01%
5,776
-4,219
-42% -$325K
2026 Q2
1 quarter
RARE icon
1207
Ultragenyx Pharmaceutical
RARE
$1.81B
$437K ﹤0.01%
+29,044
New +$697K
2026 Q3
0 quarters
SRZN icon
1208
Surrozen
SRZN
$605M
$436K ﹤0.01%
13,557
– –
2025 Q4
3 quarters
GM icon
1209
General Motors
GM
$69.3B
$436K ﹤0.01%
5,658
-14,849
-72% -$1.24M
2026 Q2
1 quarter
VLOSW icon
1210
Velos Acquisition I Corp Warrant
VLOSW
$435K ﹤0.01%
1,010,603
– –
2024 Q4
7 quarters
SUNB icon
1211
Sunbelt Rentals Holdings
SUNB
$33B
$433K ﹤0.01%
+5,919
New +$441K
2026 Q3
0 quarters
MP icon
1212
MP Materials
MP
$6.41B
$432K ﹤0.01%
+9,137
New +$464K
2026 Q3
0 quarters
BCCQW icon
1213
Bleichroeder Acquisition Corp III Warrant
BCCQW
$428K ﹤0.01%
+475,000
New +$409K
2026 Q3
0 quarters
EGP icon
1214
EastGroup Properties
EGP
$10.5B
$427K ﹤0.01%
+2,162
New +$444K
2026 Q3
0 quarters
IPFXW icon
1215
Inflection Point Acquisition Corp VI Warrant
IPFXW
$5.06M
$419K ﹤0.01%
566,666
– –
2026 Q2
1 quarter
TYRA icon
1216
Tyra Biosciences
TYRA
$1.35B
$419K ﹤0.01%
19,151
-2,000
-9% -$55K
2026 Q2
1 quarter
GSRVR icon
1217
GSR V Acquisition Corp Rights
GSRVR
$418K ﹤0.01%
+280,714
New +$434K
2026 Q3
0 quarters
TT icon
1218
Trane Technologies
TT
$89.7B
$418K ﹤0.01%
925
-2,055
-69% -$945K
2026 Q2
1 quarter
CMS icon
1219
CMS Energy
CMS
$21.9B
$418K ﹤0.01%
+6,624
New +$465K
2026 Q3
0 quarters
BMY icon
1220
Bristol-Myers Squibb
BMY
$122B
$413K ﹤0.01%
6,623
-323,528
-98% -$20.4M
2024 Q3
8 quarters
AISPW icon
1221
Airship AI Holdings Warrants
AISPW
$9.14M
$412K ﹤0.01%
1,174,137
+4,447
+0.4% +$2.2K
2024 Q4
7 quarters
CRGY icon
1222
Crescent Energy
CRGY
$4.55B
$407K ﹤0.01%
+31,600
New +$387K
2026 Q3
0 quarters
TACOW icon
1223
Berto Acquisition Corp Warrant
TACOW
$8.01M
$406K ﹤0.01%
625,000
– –
2025 Q2
5 quarters
COPR.WS icon
1224
Idaho Copper Warrant
COPR.WS
$406K ﹤0.01%
+269,743
New +$410K
2026 Q3
0 quarters
QURE icon
1225
uniQure
QURE
$1.42B
$405K ﹤0.01%
+16,781
New +$728K
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.